SC-1011
- Generic Name
- SC-1011
The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects.
- First Posted Date
- 2023-12-07
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Guangzhou JOYO Pharma Co., Ltd
- Target Recruit Count
- 55
- Registration Number
- NCT06160440
- Locations
- 🇨🇳
First Affiliated Hospital of Guang Zhou University of Chinese Medicine, Guangzhou, Guang Dong, China
Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects
Phase 1
Completed
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- Drug: Placebo tablet
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Guangzhou JOYO Pharma Co., Ltd
- Target Recruit Count
- 45
- Registration Number
- NCT06135363
- Locations
- 🇨🇳
Shanghai Xuhui District Central Hospital, Shanghai, Shanghai, China
SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
Phase 2
Recruiting
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- Drug: Placebo comparator
- First Posted Date
- 2023-11-09
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Guangzhou JOYO Pharma Co., Ltd
- Target Recruit Count
- 210
- Registration Number
- NCT06125327
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath